SGLT2 inhibitors may worsen heart failure outcomes from chemotherapy, highlighting the need for further long-term studies on ...
Florida Cancer Specialists & Research Institute Shaping the Future of Cancer Care at Global Congress
Oral Presentation to be Featured on Initial Results of a First-in-Human Study for a Promising Targeted Therapy for ...
I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.
NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint ...
Apnimed Inc., a pharmaceutical company developing first-in-class oral drugs that address the root causes of obstructive sleep apnea (OSA) and other sleep-related breathing diseases, today announced ...
On Friday 17th October, the European Society for Medical Oncology’s Annual Meeting 2025 kicked off, with the opening press ...
Positive opinion based on results of Phase 3 C-POST trial that show Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence ...
REDMOND, Wash. and PRINCETON, N.J., Oct. 17, 2025 /PRNewswire/ -- SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers ...
MIT and Harvard scientists recently created engineered CAR-NK cells that hide from the immune system and more effectively ...
As a Committee she heads continues to investigate the assassination of President John F. Kennedy in 1963, Rep. Anna Paulina ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback